FDA Adverse Event Injury Summary report: N

ESPRIT

MDR report key: 3201581 · Received June 28, 2013

Report

Report Number
1000165971-2013-00316
Event Type
Injury
Date Received
June 28, 2013
Date of Event
June 14, 2013
Report Date
June 18, 2013
Manufacturer
SORIN GROUP ITALIA, S.R.L.
Product Code
NVZ
PMA / PMN Number
P950029
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4) 2013. THIS EVENT CONCERNS A DEVICE THAT WAS MFG AND USED OUTSIDE THE UNITED STATES. ANALYSIS IS PENDING.

Description of Event or Problem · 1

REPORTEDLY, ON (B)(6) 2013, THE VENTRICULAR PACING IMPEDANCE MEASURED THROUGH SMARTCHECK (PROGRAMMER FEATURE) WAS ABOVE 3000 OHM AND THE VENTRICULAR PACING THRESHOLD COULD NOT BE MEASURED. PACING THRESHOLD AND IMPEDANCE TESTS WERE PERFORMED (WITHOUT SMARTCHECK FEATURE) AND NORMAL MEASUREMENT WERE OBTAINED AFTERWARDS. REVIEW OF THE RECORDED EPISODES LED TO A SUSPICION OF A LEAD ISSUE; IN ADDITION, THE V LEAD IMPEDANCE CURVE WAS NOT AVAILABLE. ACCORDING TO PRELIMINARY ANALYSIS RESULTS, VENTRICULAR LEAD ISSUE/LEAD CONNECTION ISSUE IS SUSPECTED. EVALUATION OF THE BENEFIT OF A RE-INTERVENTION HAS BEEN RECOMMENDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
295414 ESPRIT NVZ SORIN GROUP ITALIA, S.R.L. ESPRIT DR 2554

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention